Validation of Correction Factors for Serum Markers for First-Trimester Down Syndrome Screening in Singleton Pregnancies Conceived with Assisted Reproduction

Publisher： Karger

E-ISSN： 1421-9964|34|4|217-224

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.34, Iss.4, 2013-10, pp. : 217-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Trimester Screening for Down Syndrome with Serum Sampling at Different Gestational Ages: The Effect on Screening Performance

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 4, 2014-08 ,pp. : 293-298

Karger

Access to resources Recommend Favorite

What about Informed Consent in First-Trimester Ultrasound Screening for Down Syndrome?

By  

Fetal Diagnosis and Therapy, Vol. 23, Iss. 3, 2008-02 ,pp. : 173-184

Karger

Access to resources Recommend Favorite

A Comparison between Maternal Serum Free β-Human Chorionic Gonadotrophin and Pregnancy-Associated Plasma Protein A Levels in First-Trimester Twin and Singleton Pregnancies

By  

Fetal Diagnosis and Therapy, Vol. 19, Iss. 2, 2004-02 ,pp. : 174-177

Karger

Access to resources Recommend Favorite

Extended First-Trimester Screening Using Multiple Sonographic Markers and Maternal Serum Biochemistry: A Five-Year Prospective Study

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-02 ,pp. : 296-301

Karger

Access to resources Recommend Favorite

Impact of Including or Removing Nuchal Translucency Measurement on the Detection and False-Positive Rates of First-Trimester Down Syndrome Screening

By  

Fetal Diagnosis and Therapy, Vol. 40, Iss. 3, 2015-12 ,pp. : 214-218

Karger

Access to resources Recommend Favorite